CN107823506A - A kind of Chinese medicine composition for treating chronic prostatitis - Google Patents
A kind of Chinese medicine composition for treating chronic prostatitis Download PDFInfo
- Publication number
- CN107823506A CN107823506A CN201711144464.XA CN201711144464A CN107823506A CN 107823506 A CN107823506 A CN 107823506A CN 201711144464 A CN201711144464 A CN 201711144464A CN 107823506 A CN107823506 A CN 107823506A
- Authority
- CN
- China
- Prior art keywords
- parts
- chinese medicine
- chronic prostatitis
- medicine composition
- capsule
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/46—Eucommiaceae (Eucommia family), e.g. hardy rubber tree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/11—Pteridophyta or Filicophyta (ferns)
- A61K36/12—Filicopsida or Pteridopsida
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/21—Amaranthaceae (Amaranth family), e.g. pigweed, rockwort or globe amaranth
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/36—Caryophyllaceae (Pink family), e.g. babysbreath or soapwort
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/39—Convolvulaceae (Morning-glory family), e.g. bindweed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/43—Cuscutaceae (Dodder family), e.g. Cuscuta epithymum or greater dodder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/63—Oleaceae (Olive family), e.g. jasmine, lilac or ash tree
- A61K36/634—Forsythia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/66—Papaveraceae (Poppy family), e.g. bloodroot
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/68—Plantaginaceae (Plantain Family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/74—Rubiaceae (Madder family)
- A61K36/748—Oldenlandia or Hedyotis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/756—Phellodendron, e.g. corktree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/90—Smilacaceae (Catbrier family), e.g. greenbrier or sarsaparilla
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a kind of Chinese medicine composition for treating chronic prostatitis, mainly it is made up of the Chinese medicine of following parts by weight：20 ~ 40 parts of the bark of eucommia, 20 ~ 40 parts of Semen Cuscutae, 10 ~ 30 parts of smilax, 10 ~ 20 parts of rhizoma imperatae, 5 ~ 15 parts of pyrrosia lingua, 10 ~ 25 parts of plantain seed, 3 ~ 20 parts of oldenlandia diffusa, 10 ~ 20 parts of the capsule of weeping forsythia, 10 ~ 28 parts of golden cypress, 5 ~ 20 parts of the seed of cowherb, 15 ~ 25 parts of the root of bidentate achyranthes, 15 ~ 25 parts of corydalis tuber, 2 ~ 20 parts of radix glycyrrhizae.The Chinese medicine composition resolving and invigoration therapies being applied simultaneously of the present invention, treats both principal and secondary aspect of disease, and has significant curative effect to treatment chronic prostatitis.
Description
Technical field
The present invention relates to technical field of traditional Chinese medicine pharmacy, especially a kind of Chinese medicine composition for treating chronic prostatitis.
Background technology
Chronic prostatitis refers to prostate under pathogen or some non-infective agent effects, and patient is ached with pelvis area
One group of disease that the symptom such as pain or discomfort, paruria is characterized.Belong to traditional Chinese medicine " essence is turbid ", " stranguria ", " gonorrhoea " category.Should
Disease is male's frequently-occurring disease, common disease, easy recurrent exerbation, is not recovered for a long time, and can cause sex dysfunction and infertility, have a strong impact on male
Physical and mental health.At present clinically doctor trained in Western medicine to treatment of chronic prostatitis based on antibiotic, ∝ ARBs, anodyne,
Effect owes ideal, and cure rate is not high, and easy recurrent exerbation.Clinically the traditional Chinese medical science differs to chronic prostatitis interpretation of the cause, onset and process of an illness understanding, disputes on
Larger, effect is also unsatisfactory.
The content of the invention
The invention discloses a kind of Chinese medicine composition for treating chronic prostatitis, resolving and invigoration therapies being applied simultaneously, treat both principal and secondary aspect of disease, to treatment
Chronic prostatitis has significant curative effect.
To achieve the above object, the technical scheme is that：
A kind of Chinese medicine composition for treating chronic prostatitis, is mainly made up of the Chinese medicine of following parts by weight：20 ~ 40 parts of the bark of eucommia,
20 ~ 40 parts of Semen Cuscutae, 10 ~ 30 parts of smilax, 10 ~ 20 parts of rhizoma imperatae, 5 ~ 15 parts of pyrrosia lingua, 10 ~ 25 parts of plantain seed, oldenlandia diffusa
3 ~ 20 parts, 10 ~ 20 parts of the capsule of weeping forsythia, 10 ~ 28 parts of golden cypress, 5 ~ 20 parts of the seed of cowherb, 15 ~ 25 parts of the root of bidentate achyranthes, 15 ~ 25 parts of corydalis tuber, radix glycyrrhizae 2
~ 20 parts.
The Chinese medicine composition of above-described treatment chronic prostatitis, preferably mainly by the Chinese medicine group of following parts by weight
Into：25 ~ 33 parts of the bark of eucommia, 22 ~ 30 parts of Semen Cuscutae, 15 ~ 25 parts of smilax, 12 ~ 18 parts of rhizoma imperatae, 8 ~ 12 parts of pyrrosia lingua, plantain seed 15 ~
22 parts, 5 ~ 10 parts of oldenlandia diffusa, 13 ~ 18 parts of the capsule of weeping forsythia, 18 ~ 23 parts of golden cypress, 10 ~ 13 parts of the seed of cowherb, 18 ~ 22 parts of the root of bidentate achyranthes, prolong
19 ~ 23 parts of Hu rope, 10 ~ 16 parts of radix glycyrrhizae.
It is furthermore preferred that mainly it is made up of the Chinese medicine of following parts by weight：It is 32 parts of the bark of eucommia, 28 parts of Semen Cuscutae, 20 parts of smilax, white
16 parts of lalang grass rhizome, 10 parts of pyrrosia lingua, 20 parts of plantain seed, 9 parts of oldenlandia diffusa, 16 parts of the capsule of weeping forsythia, 21 parts of golden cypress, 11 parts of the seed of cowherb, ox
20 parts of knee, 21 parts of corydalis tuber, 13 parts of radix glycyrrhizae.
Further, Chinese medicine composition described above is prepared into receptible all formulations in pharmacy.Preferably, it is described
Formulation is water decoction, tablet, capsule or oral liquid.
The Chinese medicine composition of above-described treatment chronic prostatitis, including 13 kinds of main compositions, wherein：
The bark of eucommia：It is sweet, it is warm-natured；Tonify the liver and kidney, strengthen muscles and bones, coordinating Chong and Conception Vessels, strengthen meridian and miscarriage prevention the effect of；Modern study shows to shut out
It is secondary that there are removing internal rubbish, strengthen human body cell metabolism, prevent muscle skeleton aging, balanced human's blood pressure, decomposer
Inner cholesterol, the pharmacological action for recovering blood vessel elasticity, diuresis heat-clearing, broad-spectrum antiseptic.
Semen Cuscutae：Seminality is sweet, warm；There are nourishing liver and kidney, benefiting male body essence and invigorating sex functions and antidiarrheal.
Smilax：It is sweet, light, it is mild-natured；There is removing toxic substances, dehumidifying, easing joint movement, be mainly used under damp and hot stranguria with turbid discharge, band,
Carbuncle swells, scrofula, mange.
Rhizoma imperatae：It is sweet, cold in nature；There are cooling blood and hemostasis, reducing fever and causing diuresis；《This warp》Record, internal lesion caused by overexertion void is thin, bowl spares benefit
Gas, except hemostasis, blood close fever and chills, diuresis.
Pyrrosia lingua：Nature and flavor are sweet, bitter, are slightly cold；There is the effect of expelling the heat-evil etc. of promoting diuresis for stranguria, clearing lung-heat；Control leaching pain, hematuria, lithangiuria, kidney
Inflammation, uterine bleeding, dysentery, cough with lung heat, chronic bronchitis, metal-inflicted wound, ulcer.
Plantain seed：It is sweet in flavor and cold in property；Function promoting diuresis for stranguria, excreting dampness antidiarrheal, clear liver and improve vision, clearing heat and eliminating phlegm；Main difficult urination, leaching
Under turbid band, oedema turgor, summer-heat and damp rush down dysentery, hot eyes hide from view, the hot cough and asthma of phlegm.
Oldenlandia diffusa：It is bitter, light, it is cold in nature；Primary efficacy is clearing heat and detoxicating, medicinal powder for relieving pain knot, promoting urination and removing dampness.
The capsule of weeping forsythia：Cool in nature, bitter；Major function heat-clearing, removing toxic substances, dissipating bind, detumescence；Control warm, erysipelas, macula, large carbuncle pyogenic infections,
Scrofula, urine leaching closes.
Golden cypress：Bitter, it is cold in nature；Heat-clearing and damp-drying drug, purging intense heat and detonicating, except hectic fever due to yin clearind deficient heat.For damp-heat dysentery, jaundice, band under,
Heat gonorrhea, tinea pedis, impotence are warded off, hectic fever due to yin labor heat, night sweat, seminal emission, sore swollen toxin, eczema itch.
The seed of cowherb：It is bitter in taste, put down；The effect of with invigorate blood circulation, lower breast detumescence, inducing diuresis for treating strangurtia；For Amenorrhea, pain
Through, agalactia, acute mastitis swelling and pain, the puckery pain of stranguria.
The root of bidentate achyranthes：It is bitter, sweet, sour, it is mild-natured；For Amenorrhea, dysmenorrhoea, soreness of waist and knee joint, muscles and bones be powerless, stranguria, oedema, headache.
Corydalis tuber：Nature and flavor acrid, bitter, warm；For promoting qi circulation and relieving pain, promoting blood circulation to remove blood stasis, traumatic injury etc..
Radix glycyrrhizae：For reconciling the strong of some drugses.
It is considered herein that chronic prostatitis, using kidney deficiency as lesion basis, damp and hot, resistance of becoming silted up is its main pathogenesis, therefore to mend
Kidney, clearing heat and promoting diuresis, it is promoting blood circulation and removing obstruction in channels be therapy.The Fang Zhongyong barks of eucommia, Semen Cuscutae with tonifying kidney and benefiting sperm, with smilax, rhizoma imperatae, pyrrosia lingua,
Plantain seed, oldenlandia diffusa, the capsule of weeping forsythia, golden cypress are with clearing heat and promoting diuresis, and with the seed of cowherb, the root of bidentate achyranthes, corydalis tuber with promoting blood circulation and removing obstruction in channels, user is sweet
Careless coordinating the drug actions of a prescription, resolving and invigoration therapies being applied simultaneously, disappear and use, treat both principal and secondary aspect of disease clearly, having significant curative effect to chronic prostatitis.
Embodiment
Below in conjunction with specific embodiment, the invention will be further described, but protection scope of the present invention is not limited to following reality
Apply example.
Embodiment 1
A kind of Chinese medicine composition for treating chronic prostatitis, is mainly made up of the Chinese medicine of following parts by weight：32 parts of the bark of eucommia, Tu silks
28 parts of son, 20 parts of smilax, 16 parts of rhizoma imperatae, 10 parts of pyrrosia lingua, 20 parts of plantain seed, 9 parts of oldenlandia diffusa, 16 parts of the capsule of weeping forsythia, golden cypress
21 parts, 11 parts of the seed of cowherb, 20 parts of the root of bidentate achyranthes, 21 parts of corydalis tuber, 13 parts of radix glycyrrhizae.
Embodiment 2
A kind of Chinese medicine composition for treating chronic prostatitis, is mainly made up of the Chinese medicine of following parts by weight：25 parts of the bark of eucommia, Tu silks
22 parts of son, 15 parts of smilax, 12 parts of rhizoma imperatae, 8 parts of pyrrosia lingua, 15 parts of plantain seed, 5 parts of oldenlandia diffusa, 13 parts of the capsule of weeping forsythia, golden cypress 18
Part, 10 parts of the seed of cowherb, 18 parts of the root of bidentate achyranthes, 19 parts of corydalis tuber, 10 parts of radix glycyrrhizae.
Embodiment 3
Mainly it is made up of the Chinese medicine of following parts by weight：33 parts of the bark of eucommia, 30 parts of Semen Cuscutae, 25 parts of smilax, 18 parts of rhizoma imperatae, pyrrosia lingua
12 parts, 22 parts of plantain seed, 10 parts of oldenlandia diffusa, 18 parts of the capsule of weeping forsythia, 23 parts of golden cypress, 13 parts of the seed of cowherb, 22 parts of the root of bidentate achyranthes, corydalis tuber
23 parts, 16 parts of radix glycyrrhizae.
Embodiment 4
A kind of Chinese medicine composition for treating chronic prostatitis, 20 parts of the bark of eucommia, 20 parts of Semen Cuscutae, 10 parts of smilax, rhizoma imperatae 10
Part, 5 parts of pyrrosia lingua, 10 parts of plantain seed, 3 parts of oldenlandia diffusa, 10 parts of the capsule of weeping forsythia, 10 parts of golden cypress, 5 parts of the seed of cowherb, 15 parts of the root of bidentate achyranthes, prolong
15 parts of Hu rope, 2 parts of radix glycyrrhizae.
Embodiment 5
A kind of Chinese medicine composition for treating chronic prostatitis, is mainly made up of the Chinese medicine of following parts by weight：40 parts of the bark of eucommia, Tu silks
40 parts of son, 30 parts of smilax, 20 parts of rhizoma imperatae, 15 parts of pyrrosia lingua, 25 parts of plantain seed, 20 parts of oldenlandia diffusa, 20 parts of the capsule of weeping forsythia, golden cypress
28 parts, 20 parts of the seed of cowherb, 25 parts of the root of bidentate achyranthes, 25 parts of corydalis tuber, 20 parts of radix glycyrrhizae.
Clinical observation：
Clinical test carries out clinical observation on the therapeutic effect to the Chinese medicine composition of embodiment 1.
1. general information
(1) case selection foundation：
With reference to《New Chinese medicine guideline of clinical investigations》Formulate：
Symptom is divided into two classes：One is lower urinary tract irritation, and two be inflammatory reaction or reflectivity pain symptom.Show as different journeys
Frequent micturition, urgent urination, the odynuria of degree, urine retention sense, urethra scorching hot, urethra occasionally has white secretion logistics when Yu Chenqi, urine are last or defecate
Go out, perineum, external genital organs area, lower abdomen, suprapubic region, waist sacrum and perianal falling inflation, pain.
Inspection is defined by clinical manifestation, prostate palpation, prostatic fluid microscopy and ultrasonic examination
(2) inclusive criteria：Possess above-mentioned a symptom or partial symptoms, that is, meet Diagnosis of Chronic Prostatitis.
(3) exclusion standard：（3.1）Benign prostate hyperplasia, prostate cancer, neurogenic bladder, deformity of urethra or narrow
Narrow and serious neurological functional disease；（3.2）Acute prostatitis；（3.3）Can not partner, such as mental patient；（3.4）It is associated with
The severe primary disease such as angiocarpy, liver, kidney or hemopoietic system；（3.7）Weakness of the spleen and the stomach person.
2. general information
Choose 85 chronic prostatitis male patients.All cases are randomly divided into by treatment group and control using simple randomization method
2 groups of group.Treatment group 42, age 40-65 year；In control group 43, age 41-63 year.The general information such as 2 groups of ages, courses of disease
Compare, the not statistically significant (P of difference>0.01).
3. clinical testing procedure
The Chinese medicine composition of the offer of the embodiment of the present invention 1 is taken by treatment group, takes 250g daily, decocting twice, each 1 time sooner or later.It is right
According to group with giving paracetamol（Kang Enbei Zhejiang Pharmaceutical Co）2g, 3 times a day orally.
Each group case disables other treatment methods at least 3 weeks before the treatment, then daily of the invention medicine pill,
1 month is 1 course for the treatment of, and curative effect is observed after 2 courses for the treatment of.Other any medicines can not be used during treatment.It should be noted during taking
Meaning diet, avoids cold and uncooked food, is greasy, be pungent.
4. judgment criteria.
Cure：Symptom is wholly absent, and treatment end is paid a return visit without recurrence after 6 months.
It is effective：The symptom overwhelming majority disappears, and treatment checks prostatic fluid routine lecithin, leucocyte meter after 2 months
Number takes a turn for the better.
Effectively：Symptom takes a turn for the better earlier above, but unobvious, the routinely improvement or constant of check prostatic fluid.
It is invalid:Symptom is conventional without improvement without improvement, check prostatic fluid.
5. clinical test results
After treating 2 courses for the treatment of, treatment group cures 35, accounts for 83.3%, effective 6, accounts for 14.3%, effective 1, account for 2.4%, always have
Efficiency is 100%；Control group cures 5, accounts for 11.6%, effective 20, accounts for 46.5%, effective 16, accounts for 37.2%, invalid 2,
Total effective rate is 95.3%.Treatment group is evident in efficacy to be better than control group, and 2 groups are compared, the statistically significant (P of difference<0.01).
6. conclusion
Water decoction made of the Chinese medicine composition of the present embodiment has the effect of tonifying kidney and benefiting sperm, clearing heat and promoting diuresis, promoting blood circulation and removing obstruction in channels, to chronic
Prostatitis patient carries out complex treatment, evident in efficacy；Do not occur the adverse reactions such as liver and kidney dysfunction during taking, show this
Invention Chinese medicine composition has preferable security.
Claims (5)
- A kind of 1. Chinese medicine composition for treating chronic prostatitis, it is characterised in that：Mainly it is made up of the Chinese medicine of following parts by weight：20 ~ 40 parts of the bark of eucommia, 20 ~ 40 parts of Semen Cuscutae, 10 ~ 30 parts of smilax, rhizoma imperatae 10 ~ 20 parts, 5 ~ 15 parts of pyrrosia lingua, 10 ~ 25 parts of plantain seed, 3 ~ 20 parts of oldenlandia diffusa, 10 ~ 20 parts of the capsule of weeping forsythia, 10 ~ 28 parts of golden cypress, king 5 ~ 20 parts of row, 15 ~ 25 parts of the root of bidentate achyranthes, 15 ~ 25 parts of corydalis tuber, 2 ~ 20 parts of radix glycyrrhizae are not stayed.
- 2. the Chinese medicine composition for the treatment of chronic prostatitis according to claim 1, it is characterised in that：Mainly it is made up of the Chinese medicine of following parts by weight：25 ~ 33 parts of the bark of eucommia, 22 ~ 30 parts of Semen Cuscutae, 15 ~ 25 parts of smilax, rhizoma imperatae 12 ~ 18 parts, 8 ~ 12 parts of pyrrosia lingua, 15 ~ 22 parts of plantain seed, 5 ~ 10 parts of oldenlandia diffusa, 13 ~ 18 parts of the capsule of weeping forsythia, 18 ~ 23 parts of golden cypress, king 10 ~ 13 parts of row, 18 ~ 22 parts of the root of bidentate achyranthes, 19 ~ 23 parts of corydalis tuber, 10 ~ 16 parts of radix glycyrrhizae are not stayed.
- 3. the Chinese medicine composition for the treatment of chronic prostatitis according to claim 1, it is characterised in that：Mainly it is made up of the Chinese medicine of following parts by weight：32 parts of the bark of eucommia, 28 parts of Semen Cuscutae, 20 parts of smilax, 16 parts of rhizoma imperatae, pyrrosia lingua 10 parts, 20 parts of plantain seed, 9 parts of oldenlandia diffusa, 16 parts of the capsule of weeping forsythia, 21 parts of golden cypress, 11 parts of the seed of cowherb, 20 parts of the root of bidentate achyranthes, corydalis tuber 21 parts, 13 parts of radix glycyrrhizae.
- 4. the Chinese medicine composition of the treatment chronic prostatitis as described in any one of claim 1 ~ 3, it is characterised in that：In described Drug composition is prepared into receptible all formulations in pharmacy.
- 5. the Chinese medicine composition for the treatment of chronic prostatitis according to claim 4, it is characterised in that：The formulation is water Decoction, tablet, capsule or oral liquid.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201711144464.XA CN107823506A (en) | 2017-11-17 | 2017-11-17 | A kind of Chinese medicine composition for treating chronic prostatitis |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201711144464.XA CN107823506A (en) | 2017-11-17 | 2017-11-17 | A kind of Chinese medicine composition for treating chronic prostatitis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN107823506A true CN107823506A (en) | 2018-03-23 |
Family
ID=61652823
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201711144464.XA Withdrawn CN107823506A (en) | 2017-11-17 | 2017-11-17 | A kind of Chinese medicine composition for treating chronic prostatitis |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN107823506A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN115779020A (en) * | 2022-11-21 | 2023-03-14 | 上海中医药大学附属龙华医院 | Traditional Chinese medicine composition for treating chronic abacterial prostatitis |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1593477A (en) * | 2003-09-11 | 2005-03-16 | 谢昌贞 | Chinese herbal medicine for treating chronic prostatitis and its preparation |
| CN101757358A (en) * | 2008-12-24 | 2010-06-30 | 天津市中宝制药有限公司 | Traditional Chinese medicine composition for treating chronic prostatitis |
-
2017
- 2017-11-17 CN CN201711144464.XA patent/CN107823506A/en not_active Withdrawn
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1593477A (en) * | 2003-09-11 | 2005-03-16 | 谢昌贞 | Chinese herbal medicine for treating chronic prostatitis and its preparation |
| CN101757358A (en) * | 2008-12-24 | 2010-06-30 | 天津市中宝制药有限公司 | Traditional Chinese medicine composition for treating chronic prostatitis |
Non-Patent Citations (2)
| Title |
|---|
| 刘灿康: "清利活血法治疗慢性前列腺炎82例", 《安徽中医临床杂志》 * |
| 吴少英: "清利补肾活血法治疗慢性前列腺炎46例", 《湖南中医药导报》 * |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN115779020A (en) * | 2022-11-21 | 2023-03-14 | 上海中医药大学附属龙华医院 | Traditional Chinese medicine composition for treating chronic abacterial prostatitis |
| CN115779020B (en) * | 2022-11-21 | 2023-09-19 | 上海中医药大学附属龙华医院 | Traditional Chinese medicine composition for treating chronic nonbacterial prostatitis |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN105535694A (en) | Traditional Chinese medicine composition for treating hyperuricemia | |
| CN102847021A (en) | Enema for treating ulcerative colitis and preparation method thereof | |
| CN106039109A (en) | Traditional Chinese medicinal liquor for preventing and treating cold dampness accumulation pattern rheumatoid arthritis | |
| CN105749153A (en) | Medicine composition for treating liver-depression kidney-deficiency premature ovarian failure | |
| CN107823506A (en) | A kind of Chinese medicine composition for treating chronic prostatitis | |
| CN104069441A (en) | Traditional Chinese medicine composition for treating urinary organs calculus | |
| CN103495122B (en) | Traditional Chinese medicine for treating urolithiasis | |
| CN108619427B (en) | Pain-relieving and acid-reducing herb tea for preventing and treating gouty arthritis | |
| CN105327171A (en) | Traditional Chinese medicine electuary for treating mastitis and preparing method thereof | |
| CN105770691A (en) | Medicinal preparation for treating cervical cancer and application thereof | |
| CN106177773B (en) | A kind of Chinese medicinal pill for treating calculi in urinary system | |
| CN104127827A (en) | Traditional Chinese medicine for treating biliary calculi | |
| CN104274720A (en) | Traditional Chinese medicine composition for removing urinary calculus and treating stranguria | |
| CN103845547A (en) | Traditional Chinese medicine decoction for treating mumps | |
| CN103520591B (en) | Chinese medicine for chronic urticaria | |
| CN103520638B (en) | A kind of Traditional Chinese medicine compound composition for the treatment of prostate hyperplasia and preparation method thereof and application thereof | |
| CN102600425B (en) | Chinese herba preparation with function of breaking stones and preparation method of Chinese herba preparation | |
| CN102302639B (en) | Traditional Chinese medicine composition for treating retention of urine | |
| CN107126527A (en) | A kind of Chinese medicine composition and its preparation for treating liver cancer | |
| CN104998346A (en) | Belt for treating dysmenorrhea and preparation method thereof | |
| CN102552798B (en) | Medicinal composition for treating cholelithiasis | |
| CN105106782A (en) | Traditional Chinese medicine composition for treating urinary calculi and preparation method thereof | |
| CN105688056A (en) | Drug for treating urinary calculi and preparation method thereof | |
| CN106266970B (en) | A kind of Chinese medicine composition treated production and cause endometritis | |
| CN104707124A (en) | Traditional Chinese medicine preparation for treating chronic endometritis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WW01 | Invention patent application withdrawn after publication | ||
| WW01 | Invention patent application withdrawn after publication |
Application publication date: 20180323 |